Open AccessLiver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir‐boosted protease inhibitor in HIV/HCV‐coinfected drug‐naïve patients
Author(s) -
Macías J,
Mallolas J,
LópezCortés LF,
Cartón JA,
Domingo P,
Moreno S,
Iribarren JA,
Neukam K,
Rodrigo A,
JiménezExpósito MJ,
Pineda JA
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p91
Subject(s) - nevirapine , medicine , efavirenz , ritonavir , regimen , gastroenterology , hepatitis c , coinfection , retrospective cohort study , pharmacology , viral load , virology , human immunodeficiency virus (hiv) , antiretroviral therapy
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK